Vitamin D levels for preventing acute coronary syndrome and mortality: Evidence of a nonlinear association

Journal of Clinical Endocrinology and Metabolism

Volumn 98, Issue 5, 2013, Pages 2160-2167

  Dror, Yosef ^a,b   Giveon, Shmuel M ^b,c   Hoshen, Moshe ^b   Feldhamer, Ilan ^b   Balicer, Ran D ^b,d   Feldman, Becca S ^b  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^b CLALIT HEALTH SERVICES   (Israel)

^c TEL AVIV UNIVERSITY   (Israel)

^d BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

LOW DENSITY LIPOPROTEIN; VITAMIN D;

ACUTE CORONARY SYNDROME; ADULT; AGE; AGED; ARTICLE; BODY MASS; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CAUSE OF DEATH; COHORT ANALYSIS; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; ELECTRONIC MEDICAL RECORD; FEMALE; FOLLOW UP; GENDER; HUMAN; HYPERTENSION; INCIDENCE; ISRAEL; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MORBIDITY; POPULATION RESEARCH; PRIORITY JOURNAL; PROSPECTIVE STUDY; SMOKING; VITAMIN BLOOD LEVEL;

ACUTE CORONARY SYNDROME; AGED; AGED, 80 AND OVER; CALCIFEDIOL; COHORT STUDIES; DIETARY SUPPLEMENTS; FEMALE; FOLLOW-UP STUDIES; HUMANS; ISRAEL; MALE; MIDDLE AGED; MORTALITY; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RISK; SEVERITY OF ILLNESS INDEX; SURVIVAL ANALYSIS; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 84877719581     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2013-1185     Document Type: Article

References (44)

1. Zittermann A, Iodice S, Pilz S, Grant WB, Bagnardi V, Gandini S. Vitamin D deficiency and mortality risk in the general population: a meta-analysis of prospective cohort studies. Am J Clin Nutr. 2012; 95:91-100.
2. Song GG, Bae SC, Lee YH. Association between vitamin D intake and the risk of rheumatoid arthritis: a meta-analysis. Clin Rheumatol. 2012; 31:1733-1739.
3. Yin L, Grandi N, Raum E, Haug U, Arndt V, Brenner H. Metaanalysis: circulating vitamin D and ovarian cancer risk. Gynecol Oncol. 2011;121:369-375.
4. Gandini S, Boniol M, Haukka J, et al. Meta-analysis of observational studies of serum 25-hydroxyvitamin D levels and colorectal, breast and prostate cancer and colorectal adenoma. Int J Cancer. 2011;128:1414-1424.
5. Vander Schueren BJ, Verstuyf A, Mathieu C. Straight from D-Heart: vitamin D status and cardiovascular disease. Curr Opin Lipidol. 2012;23:17-23.
6. Ramagopalan SV, Heger A, Berlanga AJ, et al. A ChIP-seq defined genome-wide map of vitamin D receptor binding: associations with disease and evolution. Genome Res. 2010;20:1352-1360.
7. Pereira F, Barbáchano A, Singh PK, Campbell MJ, Muñoz A, Larriba MJ. Vitamin D has wide regulatory effects on histone demethylase genes. Cell Cycle. 2012;11:1081-1089.
8. Liu L, Chen M, Hankins SR, et al for the Drexel Cardiovascular Health Collaborative Education, Research, and Evaluation Group. Serum 25-hydroxyvitamin D concentration and mortality from heart failure and cardiovascular disease, and premature mortality from all-cause in United States adults. Am J Cardiol. 2012;110:834- 839.
9. Brondum-Jacobsen P, Nordestgaard BG, Schnohr P, Benn M. 25- hydroxyvitamin D and symptomatic ischemic stroke: an original study and meta-analysis. Ann Neurol. 2013;73:38-47.
10. Martins D, Wolf M, Pan D, et al. Prevalence of cardiovascular risk factors and the serum levels of 25-hydroxyvitamin D in the United States: data from the Third National Health and Nutrition Examination Survey. Arch Intern Med. 2007;167:1159-1165.
11. Anderson JL, May HT, Horne BD, et al and the Intermountain Heart Collaborative (IHC) Study Group. Relation of vitamin D deficiency to cardiovascular risk factors, disease status, and incident events in a general healthcare population. Am J Cardiol. 2010;106: 963-968.
12. Pilz S, Tomaschitz A, Maerz W, et al. Vitamin D, cardiovascular disease and mortality. Clin Endocrinol. 2011;75:575-584.
13. Parker J, Hashmi O, Dutton D, et al. Levels of vitamin D and cardiometabolic disorders: systematic review and meta-analysis. Maturitas. 2010;65:225-236.
14. Grandi NC, Breitling LP, Brenner H. Vitamin D and cardiovascular disease: systematic review and meta-analysis of prospective studies. Prev Med. 2010;51:228-233.
15. Wang L, Song Y, Manson JAE, et al. Circulating 25-hydroxy-vitamin D and risk of cardiovascular disease. A meta-analysis of prospective studies. Circ Cardiovasc Qual Outcomes. 2012;5:819- 829.
16. Pittas AG, Chung M, Trikalinos T, et al. Systematic review: vitamin D and cardiometabolic outcomes. Ann Intern Med. 2010;152:307- 314.
17. Tomson J, Emberson J, Hill M, et al. Vitamin D and risk of death from vascular and non-vascular causes in the Whitehall study and meta-analyses of 12 000 deaths [published online November 16, 2012]. Eur Heart J. doi:10.1093/eurheartj/ehs426.
18. Lim S, Shin H, Kim MJ, et al. Vitamin D inadequacy is associated with significant coronary artery stenosis in a community-based elderly cohort: the Korean longitudinal study on health and aging. J Clin Endocrinol Metab. 2012;97:169-178.
19. Bjelakovic G, Gluud LL, Nikolova D, et al. Vitamin D supplementation for prevention of mortality in adults. Cochrane Database Syst Rev. 2011;7:CD007470.
20. Murdoch DR, Slow S, Chambers ST, et al. Effect of vitamin D3 supplementation on upper respiratory tract infections in healthy adults: the VIDARIS randomized controlled trial. JAMA. 2012;308: 1333-1339.
21. Gepner AD, Ramamurthy R, Krueger DC, Korcarz CE, Binkley N, Stein JH. A prospective randomized controlled trial of the effects of vitamin D supplementation on cardiovascular disease risk. PLoS One. 2012;7:e36617.
22. Haines ST, Park SK. Vitamin D supplementation: what's known, what to do, and what's needed. Pharmacotherapy. 2012;32:354- 382.
23. Lehouck A, Mathieu C, Carremans C, et al. High doses of vitamin Dto reduce exacerbations in chronic obstructive pulmonary disease: a randomized trial. Ann Intern Med. 2012;156:105-114.
24. Sanders KM, Stuart AL, Williamson EJ, et al. Annual high-dose oral vitamin D and falls and fractures in older women: a randomized controlled trial. JAMA. 2010;303:1815-1822.
25. Vacek JL, Vanga SR, Good M, Lai SM, Lakkireddy D, Howard PA. Vitamin D deficiency and supplementation and relation to cardiovascular health. Am J Cardiol. 2012;109:359-363.
26. Dawson-Hughes B, Harris SS. High-dose vitamin D supplementation: too much of a good thing? JAMA. 2010;303:1861-1862.
27. Holis BW. Measuring 25-hydroxyvitamin D in a clinical environment: challenges and needs. Am J Clin Nutr. 2008;88:507S-510S.
28. Haklai Z, Goldberger N, Aburbeh M. Leading causes of death in Israel (2000-2009). 2012. Jerusalem, Ministry of Health. Available: http://www.health.gov.il/PublicationsFiles/Death2000-2009.pdf.
29. Melamed ML, Michos ED, Post W, Astor B. 25-Hydroxyvitamin D levels and the risk of mortality in the general population. Arch Intern Med. 2008;168:1629-1637.
30. Michaëlsson K, Baron JA, Snellman G, et al. Plasma vitamin D and mortality in older men: a community-based prospective cohort study. Am J Clin Nutr. 2010;92:841-848.
31. Wang TJ, Pencina MJ, Booth SL, et al. Vitamin D deficiency and risk of cardiovascular disease. Circulation. 2008;117:503-511.
32. Tuohimaa P, Tenkanen L, Ahonen M, et al. Both high and low levels of blood vitamin D are associated with a higher prostate cancer risk: a longitudinal, nested case-control study in the nordic countries. Int J Cancer. 2004;108:104-108.
33. Durup D, Jørgensen HL, Christensen J, Schwarz P, Heegaard AM, Lind B. A reverse J-shaped association of all-cause mortality with serum 25-hydroxyvitamin D in general practice: the CopD Study. J Clin Endocr Metab. 2012;97:2644-2652.
34. Johansson H, Oden A, Kanis J, et al. Low serum vitamin D is associated with increased mortality in elderly men: MrOS Sweden. Osteoporos Int. 2012;23:991-999.
35. Signorello LB, Han X, Cai Q, et al. A prospective study of serum 25-hydroxyvitamin D levels and mortality among African Americans and non-African Americans. Am J Epidemiol. 2013; 177:171- 179.
36. Zittermann A, Kuhn J, Dreier J, Knabbe C, Gummert JF, Borgermann J. Vitamin D status and the risk of major adverse cardiac and cerebrovascular events in cardiac surgery [published online January 13, 2013]. Eur Heart J. doi:10.1093/eurheartj/ehs468.
37. Gallagher JC, Sai A, Templin T 2nd, Smith L. Dose response to vitamin D supplementation in postmenopausal women: a randomized trial. Ann Intern Med. 2012;156:425-437.
38. Saliba W, Rennert HS, Kershenbaum A, Rennert G. Serum 25(OH)D concentrations in sunny Israel. Osteoporos Int. 2012;23: 687-694.
39. Meyer HE, Robsahm TE, Bjorge T, Brustad M, Blomhoff R. Vitamin D, season, and risk of prostate cancer: a nested case-control study within Norwegian health studies. Am J Clin Nutr. 2013;97: 147-154.
40. Bischoff-Ferrari HA, Dawson-Hughes B, Staehelin HB, et al. Fall prevention with supplemental and active forms of vitamin D: a metaanalysis of randomised controlled trials. BMJ. 2009;339:b3692.
41. Rosen CJ, Abrams SA, Aloia JF, et al. IOM committee members respond to Endocrine Society Vitamin D Guideline. J Clin Endocrinol Metab. 2012;97:1146-1152.
42. Reddy GS, Omdahl JL, Robinson M, et al. 23-Carboxy- 24,25,26,27- tetranorvitamin D3 (calcioic acid) and 24-carboxy- 25,26,27-trinorvitamin D3 (cholacalcioic acid): end products of 25- hydroxyvitamin D3 metabolism in rat kidney through C-24 oxidation pathway. Arch Biochem Biophys. 2006;455:18-30.
43. Jorde R, Svartberg J, Joakimsen RM, Coucheron DH. Plasma profile of microRNA after supplementation with high doses of vitamin D3 for 12 months. BMC Res Notes. 2012;5:245.
44. Zittermann A, Prokop S, Gummert JF, Borgermann J. Safety issues of vitamin D supplementation. Anti-Cancer Agents Med Chem. 2013;13:4-10.